SCHEMBL13298466

SCHEMBL13298466

c1ccc([SiH2]c2ccc3c(-c4ccncc4)c4ccccc4c(-c4cc5ccccc5c5ccccc45)c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.40
▸ ALOX5 P09917 2/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ IMPDH2 P12268 2/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ RECQL P46063 2/20 0.33
▸ SOS1 Q07889 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NISCH Q9Y2I1 1/20 0.33
▸ MAPK1 P28482 2/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ ESR1 P03372 2/20 0.32
▸ ESR2 Q92731 2/20 0.32
▸ HSD17B1 P14061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298464 1.00 CYP11B1 (0.40) CYP11B1ALOX5KDM4EALDH1A1MAPT
SCHEMBL13298470 0.91 ALOX5 (0.40) CYP11B1ALOX5KDM4EALDH1A1MAPT
SCHEMBL13298484 0.91 ALOX5 (0.40) CYP11B1ALOX5KDM4EALDH1A1MAPT
SCHEMBL13298489 0.88 ALOX5 (0.38) CYP11B1ALOX5KDM4EALDH1A1MAPT
SCHEMBL13298488 0.88 ALOX5 (0.38) CYP11B1ALOX5KDM4EALDH1A1MAPT
SCHEMBL13298474 0.88 IMPDH2 (0.41) KDM4EALDH1A1MAPTHPGDIMPDH2
SCHEMBL13298465 0.88 KDM4E (0.41) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL13298468 0.88 KDM4E (0.41) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL13298473 0.87 NOTUM (0.42) KDM4EALDH1A1MAPTHPGDIMPDH2
SCHEMBL13298462 0.87 NOTUM (0.42) KDM4EALDH1A1MAPTHPGDIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 CYP11B1 2489/4885ALOX5 764/4885KDM4E 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback